| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |